Genprex
GNPX
28 hedge funds and large institutions have $28.7M invested in Genprex in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
72% more capital invested
Capital invested by funds: $16.7M → $28.7M (+$12M)
27% more funds holding
Funds holding: 22 → 28 (+6)
0% more ownership
Funds ownership: 0% → 0% (+0%)
33% less call options, than puts
Call options by funds: $1.73M | Put options by funds: $2.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$773K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$464K |
| 3 |
BlackRock
New York
|
+$309K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$155K |
| 5 |
JP Morgan Chase
New York
|
+$155K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$309K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$155K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$155K |
| 4 |
FWM
Frontier Wealth Management
Kansas City,
Missouri
|
-$57K |
| 5 |
Squarepoint
New York
|
-$54K |
GNPX Hedge Fund Activity: Q4 2020 in Review
28 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q4 2020, worth a combined $28.7M — up 72% from $16.7M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new GNPX positions and 2 closed out — a net gain of 6 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, adding an estimated $773K. The largest seller was Susquehanna International Group, cutting an estimated $309K.
- 28 institutional investors held Genprex (GNPX) as of Q4 2020, up from 22 in Q3 2020.
- Funds reported $28.7M of Genprex stock for Q4 2020, up 72% quarter-over-quarter.
- 8 funds opened new Genprex positions in Q4 2020 and 2 closed out, a net change of +6 holders.
- The largest Genprex buyer in Q4 2020 was Vanguard Group, an estimated $773K added.
- The largest Genprex seller in Q4 2020 was Susquehanna International Group, an estimated $309K sold.
Based on aggregated 13F filings for Q4 2020.